Prospective clinical trial – Boston Strategic Partners, Inc.

Effects of injectable HPβCD-diclofenac on the human delayed rectifier potassium channel current in vitro and on proarrhythmic QTc in vivo

Carr DB, McDonnell Moorehead T, Bouchard A, et al. Effects of injectable HPβCD-diclofenac on the human delayed rectifier potassium channel current in vitro and on proarrhythmic QTc in vivo. Clin Ther. 2013;35(5):646-658. doi:10.1016/j.clinthera.2013.03.014. View article

Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation

Posted by katarinachin in Publications

Kao DP, Davis G, Aleong R, et al. Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation. Eur J Heart Fail. 2013;15(3):324-333. doi:10.1093/eurjhf/hfs181. View article

Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms

Posted by katarinachin in Publications

O’Connor CM, Fiuzat M, Carson PE, et al. Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms. Stoll M, ed. PLoS One. 2012;7(10):e44324. doi:10.1371/journal.pone.0044324. View article

Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production

Posted by katarinachin in Publications

Merrigan M, Venugopal A, Mallozzi M, et al. Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production. J Bacteriol. 2010;192(19):4904-4911. doi:10.1128/JB.00445-10. View article